Showing results (31-40 of 85) with videos related to
Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapyBruce D Minsky, Thomas F Pajak, Robert J Ginsberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2008
Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113Jaffer A Ajani, Kathryn Winter, Ritsuko Komaki, et al.Cancer|October 13, 2011
Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancerDavid H Ilson, Bruce D Minsky, Geoffrey Y Ku, et al.Journal of the American College of Surgeons|February 21, 2009
Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancerDerek G Power, Mark A Schattner, Hans Gerdes, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 20, 2009
A phase II study of flavopiridol (Alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancerRichard D Carvajal, Archie Tse, Manish A Shah, et al.American Journal of Clinical Oncology|August 6, 2010
Targeting mutated K-ras in pancreatic adenocarcinoma using an adjuvant vaccineGhassan K Abou-Alfa, Paul B Chapman, Jonas Feilchenfeldt, et al.British Journal of Cancer|February 10, 2017
Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancerTalia Golan, Tal Sella, Eileen M O'Reilly, et al.Investigational New Drugs|June 25, 2010
A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinomaManish A Shah, Derek G Power, Hedy L Kindler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinomaManish A Shah, Ramesh K Ramanathan, David H Ilson, et al.Cancer|May 7, 2016
Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinomaGeoffrey Y Ku, Anuja Kriplani, Yelena Y Janjigian, et al.Pageof 9